June 6 (Reuters) – The Department of Health and Human Services (HHS) said on Monday it had instructed monkeypox vaccine manufacturer Bavarian Nordic (BAVA.CO) to deliver an additional 36,000 doses this week as part of a drawdown from a U.S. vaccine stockpile.
The Danish company, which developed the vaccine with the support of HHS’ Biomedical Advanced Research and Development Authority, still has more than 1 million government-owned doses of the vaccine on hand. Another 16.4 million doses of vaccine could be finished if needed, HHS said.
During a news briefing last week, HHS official Dawn O’Connell said Bavarian Nordic can store the vaccine at a lower temperature than is possible once in the stockpile, extending the vaccine’s shelf life by about two years.
In addition to the Bavarian Nordic vaccine, the United States has more than 100 million doses of ACAM2000, a smallpox vaccine from Emergent BioSolutions Inc (EBS.N), that is also effective against monkeypox.